Xtx Topco LTD Bio Affinity Technologies, Inc. Transaction History
Xtx Topco LTD
- $1.13 Billion
- Q4 2024
A detailed history of Xtx Topco LTD transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 10,616 shares of BIAF stock, worth $2,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,616
Previous 11,264
5.75%
Holding current value
$2,760
Previous $23,000
60.87%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BIAF
# of Institutions
17Shares Held
536KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA261KShares$67,8250.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.6KShares$25,8830.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC46.3KShares$12,0390.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$7,2500.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$4,5760.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $709K
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...